Rising healthcare expenditure, growing geriatric population, increasing incidence of chronic diseases, patent expiration of blockbuster drugs, and increased consumption of generic drugs have created ...

According to Nova One Advisor, the global high potency API contract manufacturing market size was estimated at USD 8.15 billion in 2024 and is expected to hit around USD 23.00 billion by 2034, poised ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

Sound process understanding and having effective controls in place are crucial in ensuring that consistent product quality is obtained during API manufacturing. The pharmaceutical contract ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

Axplora is strategically consolidating ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the ...

(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...

Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals. The year 2011 was another year of transition for fine-chemical ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...